Clinical Trials
37 trialsTesting the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
National Cancer Institute (NCI)
QL1706 Plus Lenvatinib in Previously Treated Penile Cancer
Sun Yat-sen University
ANTARES
Instituto do Cancer do Estado de São Paulo
MH-Penile-002
West China Hospital
A Study of Becotatug Vedotin Combined With Pucotenlimab in the Treatment of EGFR-Positive Advanced Penile Cancer
Fudan University
E7 TCR-T Cell Immunotherapy for Human Papillomavirus (HPV) Associated Cancers
Rutgers, The State University of New Jersey
Pembrolizumab in Treating Patients With Rare Tumors That Cannot Be Removed by Surgery or Are Metastatic
M.D. Anderson Cancer Center
Nivolumab Combined With Ipilimumab for Patients With Advanced Rare Genitourinary Tumors
Dana-Farber Cancer Institute
A Study of Avelumab in Penile Cancer Who Are Unfit for or Have Progressed After Platinum-Based Chemotherapy
University Health Network, Toronto
Enfortumab Vedotin for the Treatment of Patients With Metastatic or Unresectable Squamous Cell Carcinoma of the Penis
Mayo Clinic
PRIAM
The Netherlands Cancer Institute
Study of the Combination Dostarlimab With Niraparib In Patients With Penile Carcinoma
H. Lee Moffitt Cancer Center and Research Institute
Ivonescimab in the Treatment of Multiple Advanced Tumors
Fudan University
BRAVA PENILE
Hospital Israelita Albert Einstein
MEGACEP
UNICANCER
ORPHEUS
MedSIR
TIP Regimen Combined With Triplizumab Neoadjuvant Therapy for Locally Advanced Penile Cancer
Sun Yat-sen University
PEVOsq
UNICANCER
Multi-cohort, Single-arm Phase II Study of Albumin-paclitaxel, Ifosfamide, and Cisplatin in the Treatment of Rare Advanced Tumors
Fudan University
DNA Plasmid-encoding Interleukin-12/HPV DNA Plasmids Therapeutic Vaccine INO-3112 and Durvalumab in Treating Patients With Recurrent or Metastatic Human Papillomavirus Associated Cancers
M.D. Anderson Cancer Center
HERCULES
Latin American Cooperative Oncology Group
AcSé
UNICANCER
PERICLES
The Netherlands Cancer Institute
PULSE
Centre Hospitalier Universitaire de Besancon
M7824 in Subjects With HPV Associated Malignancies
National Institutes of Health Clinical Center (CC)
JAVA-P
University Hospitals Bristol and Weston NHS Foundation Trust
Trial of Pembrolizumab for Advanced Penile Squamous Cell Carcinoma
University of Alabama at Birmingham
TIP (Paclitaxel + Ifosfamide + Cisplatin) Combined With Nimotuzumab & Triprilimab as Neoadjuvant Treatment in Locally Advanced Penile Cancer
Sun Yat-sen University
HER-Uro01
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Vaccine Therapy in Preventing Human Papillomavirus Infection in Young HIV-Positive Male Patients Who Have Sex With Males
AIDS Malignancy Consortium
VinCaP
Institute of Cancer Research, United Kingdom
S0224, Docetaxel in Treating Patients With Locally Advanced or Metastatic Penile Cancer (TERMINATED)
SWOG Cancer Research Network
Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Human Papillomavirus-Associated Cancers
National Institutes of Health Clinical Center (CC)
External-Beam Radiation Therapy With or Without Indinavir and Ritonavir in Treating Patients With Brain Metastases
National Cancer Institute (NCI)
Irinotecan and Cisplatin in Treating Patients With Locally Advanced or Metastatic Penile Cancer
European Organisation for Research and Treatment of Cancer - EORTC
Neoadjuvant Chemotherapy for Patients With Squamous Cell Carcinoma of the Penis
M.D. Anderson Cancer Center
Isotretinoin Plus Interferon in Treating Patients With Recurrent Cancer
Hoag Memorial Hospital Presbyterian